ResearcherKorea UniversityNo recent work listed
Jong Jin Hyun
Matched on ORCID iD 0000-0002-5632-7091; OpenAlex author ID A5060565615. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 7
- Prognostic Impact of Minimal Pelvic Fluid in Locally Advanced Pancreatic Cancer: A Multicenter Retrospective Study. Co-author DOI 10.5152/tjg.2023.23309↗
- Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland. Co-author DOI 10.1002/jso.25498↗
- [Relief of Cancer Pain in Patients with Pancreatic Cancer]. First author DOI 10.4166/kjg.2019.74.2.81↗
- Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer. Co-author DOI 10.4251/wjgo.v10.i12.505↗
- Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. Co-author DOI 10.4251/wjgo.v8.i7.555↗
- Rare case of pancreatic cancer with leptomeningeal carcinomatosis. Last author DOI 10.3748/wjg.v21.i3.1020↗
- Expression of heat shock protein 70 modulates the chemoresponsiveness of pancreatic cancer. Co-author DOI 10.5009/gnl.2013.7.6.739↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jung Wan Choe · 2 shared papers, 2019–2023 · strength 0.37
- Jin‐Seok Park · 1 shared paper, 2023 · strength 0.17
- Jungnam Lee · 1 shared paper, 2023 · strength 0.17
- Don Haeng Lee · 1 shared paper, 2023 · strength 0.17
- Jae Hee Cho · 1 shared paper, 2023 · strength 0.17
- Sung Ill Jang · 1 shared paper, 2023 · strength 0.17
- Chang‐Il Kwon · 1 shared paper, 2023 · strength 0.17
- Hong Sik Lee · 3 shared papers, 2013–2016 · strength 0.14
- Paper Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotini… DOI 10.4251/wjgo.v8.i7.555↗
- Paper Rare case of pancreatic cancer with leptomeningeal carcinomatosis. DOI 10.3748/wjg.v21.i3.1020↗
- Paper Expression of heat shock protein 70 modulates the chemoresponsiveness of pancreatic cancer. DOI 10.5009/gnl.2013.7.6.739↗
- Yoon Tae Jeen · 3 shared papers, 2013–2016 · strength 0.14
- Paper Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotini… DOI 10.4251/wjgo.v8.i7.555↗
- Paper Rare case of pancreatic cancer with leptomeningeal carcinomatosis. DOI 10.3748/wjg.v21.i3.1020↗
- Paper Expression of heat shock protein 70 modulates the chemoresponsiveness of pancreatic cancer. DOI 10.5009/gnl.2013.7.6.739↗
- Hoon Jai Chun · 3 shared papers, 2013–2016 · strength 0.14
- Paper Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotini… DOI 10.4251/wjgo.v8.i7.555↗
- Paper Rare case of pancreatic cancer with leptomeningeal carcinomatosis. DOI 10.3748/wjg.v21.i3.1020↗
- Paper Expression of heat shock protein 70 modulates the chemoresponsiveness of pancreatic cancer. DOI 10.5009/gnl.2013.7.6.739↗
- Adnan A. Alseidi · 1 shared paper, 2019 · strength 0.10
- John Bart Rose · 1 shared paper, 2019 · strength 0.10
- Flavio G. Rocha · 1 shared paper, 2019 · strength 0.10
- Richard A. Kozarek MD · 1 shared paper, 2019 · strength 0.10
- Scott W. Helton · 1 shared paper, 2019 · strength 0.10
- Jae Min Lee · 2 shared papers, 2015–2016 · strength 0.10
- Chang Duck Kim · 2 shared papers, 2013–2016 · strength 0.09
- Jun Kyu Lee · 1 shared paper, 2018 · strength 0.08
- Moon Jae Chung · 1 shared paper, 2018 · strength 0.08
- Huapyong Kang · 1 shared paper, 2018 · strength 0.08
- Sang Hyub Lee · 1 shared paper, 2018 · strength 0.08
- Ho Gak Kim · 1 shared paper, 2018 · strength 0.08
- Seungmin Bang · 1 shared paper, 2018 · strength 0.08
- In Kyung Yoo · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.